Positive response to trastuzumab deruxtecan in a patient with HER2-mutant NSCLC after multiple lines therapy, including T-DM1: a case report
Article in Frontiers in Oncology (January 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Frontiers in Oncology (January 2024)
Article in Reactions Weekly (February 2023)